MFG
HUMA icon

Mendota Financial Group’s Humacyte HUMA Stock Holding History

Mendota Financial Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$2.72K – 749
2024
Q3 		$2.72K Hold
500
– – ﹤0.01% 301
2024
Q2 		$2.4K Hold
500
– – ﹤0.01% 272
2024
Q1 		$1.55K Hold
500
– – ﹤0.01% 291
2023
Q4 		$1.42K Hold
500
– – ﹤0.01% 328
2023
Q3 		$1.47K Hold
500
– – ﹤0.01% 258
2023
Q2 		$1.43K Hold
500
– – ﹤0.01% 257
2023
Q1 		$3.53K Hold
500
– – ﹤0.01% 264
2022
Q4 		$1.05K Buy
+500
New +$1.52K ﹤0.01% 275

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mendota Financial Group's HUMA Position: Q4 2024 in Review

Mendota Financial Group sold out of Humacyte (HUMA) in Q4 2024, closing a stake of 500 shares — an estimated $2.72K sold.

Mendota Financial Group first reported a position in HUMA in Q4 2022 and held it in 8 quarters. The position peaked at $3.53K in Q1 2023. 162 funds tracked by Wall St. Rank hold HUMA as of Q4 2024.

  • Mendota Financial Group reported no remaining Humacyte position as of Q4 2024 after selling out during the quarter.
  • Mendota Financial Group sold 500 Humacyte shares in Q4 2024, an estimated $2.72K.
  • Mendota Financial Group first reported a position in Humacyte in Q4 2022 and held it in 8 quarters.
  • Mendota Financial Group's Humacyte position peaked at $3.53K in Q1 2023.
  • 162 funds tracked by Wall St. Rank held Humacyte as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.